Header Logo

Connection

MICHAEL ITTMANN to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Carcinoma, Hepatocellular.
MICHAEL ITTMANN
Connection Strength
0.053
Carcinoma, Hepatocellular
  1. ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC). PLoS One. 2013; 8(8):e72829.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.